Investegate |Samsung Bioepis Announcements | Samsung Bioepis: Health Canada Approves Samsung Bioepis and Biogen's BYOOVIZ™ (SB11), LUCENTIS® Biosimilar (ranibizumab)
Investegate announcements from Samsung Bioepis, Health Canada Approves Samsung Bioepis and Biogen’s BYOOVIZ™ (SB11), LUCENTIS® Biosimilar (ranibizumab)